This year we will be opening the conference on Wednesday afternoon starting with our Poster Display at the Cube, this will be followed by a catered networking event with Bionics Gamechangers at Room Three Sixty.
You can look forward to 2 packed days of conferencing at KG-E5 Function Centre, come along to listen to an exciting lineup of external and internal scientific presentations, an industry panel discussion, E/MCR presentations, and HDR rapid-fire talks.
As previously, all conference delegates are invited to attend the Conference Dinner on Thursday evening, this year we are holding it at a secret location on Kelvin Grove campus.
Prof Lim Chwee Teck | National Univ
ersity of Singapore Biomedical Engineering
Professor Lim is the inaugural NUSS chair Professor at the Department of Biomedical Engineering & Founding Principal Investigator at the Mechanobiology Institute. He is also the Director of the Institute for Health Innovation & Technology (iHealthtech) & Founding Director of the Singapore Health Technologies Consortium. Prof Lim’s research interests are interdisciplinary & include human disease mechanobiology, microfluidic biomedical technologies for human disease diagnosis & precision medicine & soft wearable technologies for healthcare applications. He has authored over 400 peer–reviewed journal papers & delivered more than 390 plenary/keynote/invited talks.
A/Professor Arnold Lining Ju | The University of Sydney, Biomedical Engineering
Associate Professor Arnold Ju received his PhD in Biomedical Engineering at Georgia Institute of Technology and Emory University, USA. In 2014, he joined the Australian Centre for Blood Diseases, Monash University, Melbourne as a junior postdoc; and relocated in 2015 to Sydney, to join the Heart Research Institute. In early 2020, Dr Ju joined the University of Sydney (USYD)’s new BME school as a senior lecturer and started up the Mechanobiology and Biomechanics Laboratory (MBL). By linking the mechanical forces behind blood flow and their effects on haematological proteins and blood clotting cells, Dr Ju has established a new field called ‘mechanobiology’. His work finds better solutions to help diagnose, treat, and control blood clotting
Commercialisation and Translation Panelists
Liz Gillies, CEO Menzies Foundation, Liz has over 25 years’ experience in a range of fields focused on initiatives for social impact. She has held roles in multiple sectors & academia. In 2018, Liz was appointed CEO of the Menzies Foundation which aspires to build a leadership movement that supports Australians to pivot to purpose, build leadership capability & contribute to the ‘greater good’.
Dr Erin Rayment, Executive Director QUT Industry Engagement. As Executive Director of Industry Engagement at QUT, Dr Rayment leads the team responsible for QUT’s engagement, partnerships & commercialisation. Erin began her career as a biomedical scientist with a PhD in tissue engineering, is a Graduate of the AICD, & is passionate about science, commercialisation & ensuring that research is able to create real world outcomes.
Andrew Bowskill, Director of Stakeholder Engagement QLD MTPConnect, As Director of Stakeholder Engagement QLD at MTPConnect, Andrew engages with a broad cross section of stakeholders including consumer groups, companies, peak bodies & Government. Andrew possess a deep understanding of industry & regulatory policy covering R&D, IP & trade agreements.
Prof Chwee Teck Lim, Director, Institute of Health Innovation & Technology (iHealthTech), National University of Singapore. Professor Lim is the inaugural NUSS chair Professor at the Department of Biomedical Engineering & Founding Principal Investigator at the Mechanobiology Institute. He is also the Director of the Institute for Health Innovation & Technology (iHealthtech) & Founding Director of the Singapore Health Technologies Consortium.
Thank you to our sponsors and trade displays
The MedTech Actuator was founded in 2018 by serial MedTech entrepreneurs and health policy experts who understood that MedTech, HealthTech and BioTech ventures require a bespoke acceleration model.
We connect the region’s broad ecosystem to empower founders to build the next wave of global MedTech, HealthTech and BioTech success stories.
Menzies Foundation aspires to raise the profile and importance of ‘outstanding’ leadership by encouraging Australians to reflect on leadership, build their leadership capability and act for the greater good.
The Foundation supports leadership platforms to explore, deepen understanding and codify approaches to leadership. Our efforts to explore the dimensions of leadership from multiple perspectives support the foundations strong focus on identifying the leadership qualities and attributes that are key to leading in an Australian and global context.
Our ultimate ambition is to build a leadership movement by sharing these insights with the Australian community and contributing to the leadership discourse.
John Morris supplies, installs and services quality scientific and specialised equipment from trusted brands. Helping you discover solutions and achieve reliable results.
Miltenyi Biotec’s mission is to advance scientific understanding and medicine by providing solutions for cell and gene therapy and biomedical research. We believe in biomedical science as the strongest driver to change the way we treat cancer, autoimmune diseases, and neurodegenerative disorders.
In Vitro Technologies is a Scientific and Medical distribution company specialising in the sale and support of scientific, clinical diagnostic, medical and related products. The company was established in 2002 and is 100% Australian owned by the multi-generational family company with over 1,200 employees throughout Australia and New Zealand – JJ Richards & Sons Pty Ltd.
In Vitro Technologies consists of five major Business Units, providing our customers with the highest quality products and services in the areas of Industrial Science, Life Science, Diagnostics, Women’s and Children’s and Infection Control.